Ardelyx(ARDX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARDX Ardelyx

盘前交易 07-21 05:43:41 EDT

5.09

-0.11

-2.12%

最高5.27	最低5.08	成交量236.81万
今开5.23	昨收5.20	日振幅3.65%
总市值12.57亿	流通市值11.20亿	总股本2.47亿
成交额1,219万	换手率1.08%	流通股本2.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARDX","market":"US","secType":"STK","nameCN":"Ardelyx","latestPrice":5.09,"timestamp":1784577600000,"preClose":5.2,"halted":0,"volume":2368081,"delay":0,"changeRate":-0.021153846153846214,"floatShares":220000000,"shares":247029387,"eps":-0.239086,"marketStatus":"盘前交易","change":-0.11,"latestTime":"07-21 05:43:41 EDT","open":5.23,"high":5.27,"low":5.08,"amount":12194509.598516298,"amplitude":0.036538,"askPrice":5.86,"askSize":100,"bidPrice":4.67,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.239086,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784640600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1403150400000,"exchange":"NASDAQ","adjPreClose":5.09,"postHourTrading":{"tag":"盘后","latestPrice":5.09,"preClose":5.09,"latestTime":"19:54 EDT","volume":19503,"amount":99359.1936,"timestamp":1784591696582,"change":0,"changeRate":0,"amplitude":0.003929},"volumeRatio":0.8469252194762804,"impliedVol":0.6655,"impliedVolPercentile":0.564},"requestUrl":"/m/hq/s/ARDX","defaultTab":"news","newsList":[{"id":"1118539675","title":"财报前瞻｜Ardelyx本季度营收预计增20.17%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1118539675","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118539675?lang=zh_cn&edition=full","pubTime":"2026-04-23 15:34","pubTimestamp":1776929640,"startTime":"0","endTime":"0","summary":"Ardelyx将于2026年04月30日美股盘后发布最新季度业绩，市场聚焦营收增速与盈利路径的边际变化。市场一致预期本季度营收约9,469.52万美元，同比增长20.17%；调整后每股收益约-0.13美元，同比下降17.92%；EBIT约-2,682.73万美元，同比下降9.44%，毛利率与净利率暂无一致预测数据可用；上季度财报与公开资料未披露面向本季度的量化指引。从一致预期看，本季营收预计同比增长20.17%，对应绝对额约9,469.52万美元，延续上季的收入扩张态势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Ardelyx本季度营收预计增20.17%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174063771","title":"异动解读 | Ardelyx与LPGA达成战略合作，股价盘中大涨9.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174063771","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174063771?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:54","pubTimestamp":1771944864,"startTime":"0","endTime":"0","summary":"生物制药公司Ardelyx（股票代码：ARDX）今日盘中股价大幅上涨9.39%，引起了市场的广泛关注。消息面上，Ardelyx与女子职业高尔夫协会（LPGA）共同宣布，双方已确立一项为期数年的战略合作伙伴关系。此次合作旨在提升公众对消化系统健康议题的认知，并致力于打破影响全球数百万患者的疾病污名化现象。这一举措被视为Ardelyx在品牌建设和公众教育方面的重要进展，有效提振了投资者信心。根据合作协议，双方将携手推动消化健康领域的公众教育，这有望增强Ardelyx的市场影响力，并为其长期发展奠定基础，从而推动了股价的显著上扬。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170303109","title":"异动解读 | Ardelyx与LPGA达成战略合作，股价盘前大涨6.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170303109","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170303109?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:20","pubTimestamp":1771939235,"startTime":"0","endTime":"0","summary":"生物制药公司Ardelyx（股票代码：ARDX）今日盘前股价大幅上涨6.80%，引起了市场关注。消息面上，Ardelyx与女子职业高尔夫协会（LPGA）共同宣布，双方已确立一项为期数年的战略合作伙伴关系。此次合作旨在提升公众对消化系统健康议题的认知，并致力于打破影响全球数百万患者的疾病污名化现象。这一合作被视为Ardelyx在品牌建设和公众教育方面的重要举措，可能有助于增强其市场影响力，从而提振了投资者信心，推动股价在盘前交易时段显著上扬。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134403386","title":"Ardelyx与LPGA达成多年合作，携手破除影响数百万人的消化健康问题污名","url":"https://stock-news.laohu8.com/highlight/detail?id=1134403386","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134403386?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:05","pubTimestamp":1771938333,"startTime":"0","endTime":"0","summary":"生物制药公司Ardelyx与女子职业高尔夫协会（LPGA）共同宣布，双方已确立一项为期数年的战略合作伙伴关系。此次合作的核心目标在于提升公众对消化系统健康议题的认知，并致力于打破长期以来困扰全球数百万患者的疾病污名化现象。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163249167","title":"财报前瞻 ｜Ardelyx本季度营收预计增7.45%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1163249167","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163249167?lang=zh_cn&edition=full","pubTime":"2026-02-12 11:22","pubTimestamp":1770866574,"startTime":"0","endTime":"0","summary":"Ardelyx将于2026年02月19日发布最新季度财报，市场当前预期本季度营收与盈利改善，关注主营产品销售放量与费用控制的协同效应。市场一致预期本季度Ardelyx营收为1.18亿美元，同比增长7.45%；预计调整后每股收益为0.01美元，同比提升173.00%；预计息税前利润为707.23万美元，同比增长40.13%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜Ardelyx本季度营收预计增7.45%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517678444","title":"Ardelyx(ARDX.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517678444","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517678444?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:32","pubTimestamp":1741386747,"startTime":"0","endTime":"0","summary":"Ardelyx(ARDX.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价15.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08063248605335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516680663","title":"Ardelyx, Inc.盘中异动 临近收盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516680663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516680663?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:33","pubTimestamp":1741033982,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时33分，Ardelyx, Inc.股票出现异动，股价大幅下跌5.04%。Ardelyx, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4621.88%、215.19%、187.27%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304043302abe69753&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304043302abe69753&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514386947","title":"Ardelyx, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386947?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:35","pubTimestamp":1740666917,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时35分，Ardelyx, Inc.股票出现异动，股价急速拉升5.00%。截至发稿，该股报5.36美元/股，成交量15.2529万股，换手率0.06%，振幅2.06%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223517989510af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223517989510af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513756039","title":"Ardelyx, Inc.2024财年实现净利润-39.14百万美元，同比增加40.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513756039","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513756039?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:00","pubTimestamp":1740326452,"startTime":"0","endTime":"0","summary":"2月24日，Ardelyx, Inc.公布财报，公告显示公司2024财年净利润为-39.14百万美元，同比增加40.76%；其中营业收入为3.34亿美元，同比增加169.35%，每股基本收益为-0.17美元。从资产负债表来看，Ardelyx, Inc.总负债2.62亿美元，其中短期债务1.56百万美元，资产负债比为1.67，流动比率为0.05。机构评级：截至2025年2月24日，当前有8家机构对Ardelyx, Inc.目标价做出预测，其中目标均价为10.06美元，其中最低目标价为5.50美元，最高目标价为13.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000120a250ce05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000120a250ce05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513162291","title":"Ardelyx, Inc.盘中异动 早盘急速跳水5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513162291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513162291?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:55","pubTimestamp":1740149749,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时55分，Ardelyx, Inc.股票出现波动，股价快速下跌5.24%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.、Omega Therapeutics, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为100.87%、88.38%、45.79%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为57.50%、35.45%、33.83%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221225549962b8133&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221225549962b8133&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126178599","title":"异动解读 | Ardelyx财报亮眼超预期 盘前股价大涨6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126178599","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126178599?lang=zh_cn&edition=full","pubTime":"2025-02-20 20:40","pubTimestamp":1740055221,"startTime":"0","endTime":"0","summary":"Ardelyx是一家生物制药公司,主要专注于肾脏和心血管疾病等领域的药物开发。在周四盘前交易中,该公司股价大涨6.92%,引发市场广泛关注。公司此前公布的2024年第四季度财报数据超出市场预期,营收和盈利双双创下新高,这是导致股价强劲表现的主因。财报数据表现亮眼,充分反映了公司业务的快速发展和盈利能力提升。投资者对Ardelyx未来的持续增长前景更加看好,因此在盘前活跃买盘涌入,推动股价大涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162116073","title":"Ardelyx第四季度2024年GAAP每股收益$0.02超出预期$0.01，销售额$1.1613亿超出预期$1.0994亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1162116073","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162116073?lang=zh_cn&edition=full","pubTime":"2025-02-20 20:38","pubTimestamp":1740055135,"startTime":"0","endTime":"0","summary":"Ardelyx报告季度每股收益为$0.02，超出分析师预期的$0.01，增长100％。相比去年同期每股盈利的亏损$，增加了116.67％。以上内容来自Benzinga Earnings专栏，原文如下：$Ardelyx$  reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $0.01 by 100 percent. This is a 116.67 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $116.13 million which beat the analyst consensus estimate of $109.94 million by 5.63 percent.  This is a 237.95 percent increase over sales o","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ardelyx第四季度2024年GAAP每股收益$0.02超出预期$0.01，销售额$1.1613亿超出预期$1.0994亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512653661","title":"Ardelyx, Inc.盘中异动 早盘股价大涨5.01%报6.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512653661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512653661?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:38","pubTimestamp":1739889528,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时38分，Ardelyx, Inc.股票出现异动，股价快速拉升5.01%。截至发稿，该股报6.08美元/股，成交量23.3018万股，换手率0.10%，振幅4.49%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182238499889fe6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182238499889fe6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506305954","title":"Ardelyx, Inc.盘中异动 早盘股价大涨5.07%报5.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506305954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506305954?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:46","pubTimestamp":1737989194,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时46分，Ardelyx, Inc.股票出现波动，股价急速拉升5.07%。截至发稿，该股报5.80美元/股，成交量34.5643万股，换手率0.15%，振幅5.07%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为1.21%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272246359874b232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272246359874b232&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505325012","title":"Ardelyx, Inc.盘中异动 早盘大幅拉升5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505325012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505325012?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:31","pubTimestamp":1737642668,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时31分，Ardelyx, Inc.股票出现波动，股价快速上涨5.54%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Exicure, Inc.、Hepion Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd、Vigil Neuroscience, Inc.较为活跃，换手率分别为1709.61%、461.62%、36.27%，振幅较大的相关个股有IDEAYA生物科学、In8Bio, Inc.、Hepion Pharmaceuticals, Inc.，振幅分别为4.88%、4.70%、4.44%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501232231089870b8db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501232231089870b8db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505724509","title":"Ardelyx, Inc.盘中异动 股价大涨5.19%报5.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505724509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505724509?lang=zh_cn&edition=full","pubTime":"2025-01-22 23:04","pubTimestamp":1737558243,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日23时04分，Ardelyx, Inc.股票出现波动，股价快速拉升5.19%。截至发稿，该股报5.17美元/股，成交量41.4071万股，换手率0.17%，振幅5.60%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122230403a22bb935&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122230403a22bb935&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504097912","title":"Ardelyx, Inc.盘中异动 大幅下挫5.02%报5.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504097912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504097912?lang=zh_cn&edition=full","pubTime":"2025-01-17 00:47","pubTimestamp":1737046078,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日00时47分，Ardelyx, Inc.股票出现波动，股价快速跳水5.02%。截至发稿，该股报5.08美元/股，成交量123.864万股，换手率0.52%，振幅5.51%。Ardelyx, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117004758abad6e16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117004758abad6e16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503267759","title":"Ardelyx, Inc.盘中异动 临近收盘股价大跌5.07%报5.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503267759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503267759?lang=zh_cn&edition=full","pubTime":"2025-01-16 04:41","pubTimestamp":1736973665,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日04时41分，Ardelyx, Inc.股票出现异动，股价大幅跳水5.07%。截至发稿，该股报5.34美元/股，成交量361.242万股，换手率1.53%，振幅7.47%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116044105960501ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116044105960501ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503585050","title":"Ardelyx, Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503585050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503585050?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:55","pubTimestamp":1736780150,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时55分，Ardelyx, Inc.股票出现波动，股价大幅上涨5.07%。Ardelyx, Inc.股票所在的生物技术行业中，整体跌幅为1.51%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为5383.40%、3159.39%、406.90%，振幅较大的相关个股有Kairos Pharma, Ltd.、Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.，振幅分别为118.35%、104.79%、102.37%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132255509864da87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132255509864da87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494335005","title":"Ardelyx, Inc.盘中异动 下午盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494335005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494335005?lang=zh_cn&edition=full","pubTime":"2024-12-28 02:00","pubTimestamp":1735322437,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日02时00分，Ardelyx, Inc.股票出现波动，股价大幅上涨5.09%。截至发稿，该股报5.06美元/股，成交量371.235万股，换手率1.57%，振幅9.04%。Ardelyx, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228020037a20c2763&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228020037a20c2763&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARDX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ardelyx.com","stockEarnings":[{"period":"1week","weight":-0.0097},{"period":"1month","weight":-0.1587},{"period":"3month","weight":-0.146},{"period":"6month","weight":-0.363},{"period":"1year","weight":0.1542},{"period":"ytd","weight":-0.1269}],"compareEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":-0.0062},{"period":"3month","weight":0.054},{"period":"6month","weight":0.0827},{"period":"1year","weight":0.1825},{"period":"ytd","weight":0.0882}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ardelyx, Inc.是一个临床阶段的生物制药公司，致力于发现，商用化的创新发展，非系统化的小分子药物治疗工作，专门在胃肠道方面，治疗心肾，胃肠和代谢性疾病。公司开发的药物发现和设计平台使它，在一个快速和成本有效的方式，去发现和设计新的候选药物。公司于2007年10月17日在特拉华成立，公司于2008年6月由nteryx更名为ardelyx。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.056449},{"month":2,"riseRate":0.25,"avgChangeRate":-0.042894},{"month":3,"riseRate":0.25,"avgChangeRate":0.001362},{"month":4,"riseRate":0.583333,"avgChangeRate":0.006132},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.125147},{"month":6,"riseRate":0.5,"avgChangeRate":0.027041},{"month":7,"riseRate":0.538462,"avgChangeRate":-0.031237},{"month":8,"riseRate":0.666667,"avgChangeRate":0.106042},{"month":9,"riseRate":0.5,"avgChangeRate":0.057062},{"month":10,"riseRate":0.333333,"avgChangeRate":0.013627},{"month":11,"riseRate":0.666667,"avgChangeRate":0.143555},{"month":12,"riseRate":0.416667,"avgChangeRate":0.014591}],"exchange":"NASDAQ","name":"Ardelyx","nameEN":"Ardelyx"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ardelyx(ARDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ardelyx(ARDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ardelyx,ARDX,Ardelyx股票,Ardelyx股票老虎,Ardelyx股票老虎国际,Ardelyx行情,Ardelyx股票行情,Ardelyx股价,Ardelyx股市,Ardelyx股票价格,Ardelyx股票交易,Ardelyx股票购买,Ardelyx股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ardelyx(ARDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ardelyx(ARDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}